Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 46254
95 % 2 2 33425 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 1.6
PDBFlex
90 % 2 2 40223
70 % 2 2 35591
50 % 2 2 25149
40 % 22 33 1376
30 % 27 40 1185
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 71708
95 % 1 1 56016
90 % 322 553 4
70 % 1517 2416 2
50 % 1898 3067 2
40 % 1898 3067 2
30 % 3859 6228 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 71707
95 % 1 1 59178
90 % 1 1 55786
70 % 1835 2965 1
50 % 1936 3117 1
40 % 1936 3117 1
30 % 3860 6228 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 71710
95 % 2 2 35609 Flexibility: Low
Max RMSD: 1.1, Avg RMSD: 1.1
PDBFlex
90 % 2 2 29809
70 % 1836 2965 1
50 % 1937 3117 1
40 % 1937 3117 1
30 % 3861 6228 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 46255
95 % 9 10 5523 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 0.9
PDBFlex
90 % 323 553 4
70 % 1518 2416 2
50 % 1899 3067 2
40 % 1899 3067 2
30 % 3862 6228 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
3 6MEE 2 B, D antibody HEPC74 Light Chain 9606
4 5UCB 2 L Fab Light Chain 9606
5 5I8C 2 B VRC34.01 Fab light chain 9606
6 5WK2 1 L M116 LIGHT CHAIN 9606
7 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
8 5VSI 2 L CH1/Ckappa Fab light chain 9606
9 6PZG 1 L NA-80 Fab light chain 9606
10 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
11 4NWU 2 L APE1551 Ab Fab light chain 9606
12 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
13 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
14 5OB5 3 L fAb Light chain 9606
15 3QQ9 1 C, L 101F LIGHT CHAIN 10090
16 5UEA 3 B, L Fab Light Chain 9606
17 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
18 3QRG 1 L Fab light chain 9606
19 3NCJ 1 L Fab15 Mut8 light chain 9606
20 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
21 4NWT 1 L APE1531 Ab Fab light chain 9606
22 3NA9 1 L Fab15 light chain 9606
23 5U6A 1 A Light Chain 9606
24 5UEK 3 L Fab 12E Light Chain 9606
25 3NAA 1 L Fab15 Mut5 light chain 9606
26 5IK3 2 B, D 1E03 Fab fragment light chain 9606
27 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
28 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
29 5IT2 2 L light chain 9606
30 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
31 6DW2 1 A 6078 Fab light chain 9606
32 6BQB 1 L MGG4 Fab light chain 9606
33 4PUB 2 L DX-2930 LIGHT CHAIN 9606
34 6B14 2 L Light chain of Fab BL3-6S97N 10090
35 5VKD 3 L Fab light chain 9606
36 5XHG 1 A, C polypeptide(L) 10090
37 3OAZ 2 K, L Fab 2G12, light chain 9606
38 6OTC 3 L sFab H3 light chain 32630
39 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
40 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
41 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
42 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
43 4JHA 2 L D25 light chain 9606
44 6B9Z 1 A Trastuzumab Fab light chain 10090
45 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
46 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
47 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
48 6PE7 2 L FAB Light chain 9606
49 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
50 6IAS 2 L Fab NKp46-1 light chain 32630
51 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
52 3P0Y 3 L Fab DL11 light chain 9606
53 6ANA 3 L LL2 Fab Light Chain 10090
54 6AOD 1 A FXIa Antibody FAB Light Chain 9606
55 6ELE 2 B, L fAB light chain 9606
56 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
57 3NAC 1 L Fab15 Mut7 light chain 9606
58 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
59 3EO9 1 L Efalizumab Fab fragment, light chain 9606
60 6N35 1 K, L Fab 2G12 light chain 9606
61 5WUV 1 L light chain 9606
62 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
63 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
64 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
65 6D0X 2 B 1210 Antibody, light chain 9606
66 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
67 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
68 6O39 1 A Antibody F2.I Fab, Light chain 9606
69 5XKU 2 B HNIgGA6 light chain 9606
70 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
71 5I18 1 L FAB LIGHT CHAIN 9606
72 3SOB 1 L antibody light chain 9606
73 6B5M 2 L CIS43 Fab Light chain 9606
74 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
75 4KQ3 1 L CNTO3186 light chain Fab 9606
76 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
77 4I77 2 L Lebrikizumab light chain Fab 9606
78 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
79 4HJG 1 A Trastuzumab light chain 9606
80 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
81 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
82 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
83 6ELJ 2 B, L fAB light chain 9606
84 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
85 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
86 6CBV 2 L Light Chain, Fab fragment 9606
87 5JW5 2 B, L MEDI8852 Light chain 9606
88 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
89 3QWO 1 B, L motavizumab light chain 10090
90 4IOI 1 A Trastuzumab light chain 9606
91 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
92 5VAG 2 B Light chain of antibody m826 9606
93 4RBP 1 K, L Fab 2G12 light chain 9606
94 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
95 6B5N 2 L CIS43 Fab Light chain 9606
96 3OAY 1 K, L Fab 2G12, light chain 9606
97 6AND 3 L Pinatuzumab Fab light chain 9606
98 5JRP 1 L marberg virus monoclonal antibody MR78 Fab light chain 9606
99 5F7E 2 L Fab light chain 9606
100 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
101 5FHA 2 L Antibody 114 Fab light chain 9606
102 5UMN 3 D, F Antibody C05, light chain 9606
103 4X7S 2 L Ig kappa chain C region residues 23-236 9606
104 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
105 3QPQ 1 C, E, I, L C1068 light chain 10090
106 6PHB 2 A, C 2530 Antibody Fab, Light Chain 9606
107 6MXR 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
108 6ELL 2 B, L fAB light chain 9606
109 2HFF 1 A, L CB2 Fab, light chain 9606
110 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
111 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606
112 6MXS 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
113 5I1L 1 A, L FAB LIGHT CHAIN 9606
114 5GGV 1 L light chain 9606
115 3L5X 1 L H2L6 LIGHT CHAIN 9606
116 5BJZ 3 H, L Synthetic antibody, Fab fragment, Light Chain 9606
117 2R8S 2 L Fab light chain 10090
118 4HKZ 1 A Trastuzumab light chain 9606
119 6DB8 3 L Fab-Light chain 32630
120 6DDR 1 A Anti-MICA Fab fragment light chain clone 13A9 10090
121 6MEH 3 L antibody HEPC74 Light Chain 9606
122 3OAU 2 L Fab 2G12, light chain 9606
123 5WEQ 1 A MR78 mutant light chain 9606
124 4ZYK 2 B, L AM14 light chain 9606
125 6DWA 1 A, L 4497 Fab Light Chain 9606
126 5E94 1 A, C Antibody Fab fragment light chain 10090
127 6MED 2 B, D, I antibody HEPC3 Light Chain 9606
128 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606
129 6ME1 2 B, D VRC34.01 Fab light chain 9606
130 5ITB 2 L anti-RSV F Fab 14N4 Light chain 9606
131 4KMT 1 L light chain O12/KAPPA Fab 9606
132 6U3Z 2 B, D V20_5A4 Light Chain Fab 9544
133 6CW3 2 B, D antibody light chain 9606
134 6BTJ 2 B, L Light chain of H7.5 Fab 9606
135 6BLI 2 B, E, H, K CB002.5 Fab Light Chain 9606
136 4XTR 3 D, F Antibody Light chain 32630
137 1RZ7 1 L Fab 48d light chain 9606
138 1RZG 2 B, D Fab 412d heavy chain 9606
139 5EA0 2 L Light chain of antibody 7968 Fab fragment 9606
140 3PGF 3 L SAB Light Chain 9606
141 6B9Y 1 A Trastuzumab Fab light chain 9606
142 2QQN 3 L Antibody light chain 9606
143 6MSY 1 L Fab 2G12, light chain 9606
144 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
145 6BAE 1 A Trastuzumab Fab light chain 10090
146 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606
147 2CMR 3 L D5 9606
148 5ZV3 3 L Light chain (kappa) of antibody CBTAU28.1 9606
149 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606
150 5CZX 3 D, L 20358 Fab light chain 9606
151 6BI0 2 L, M Trastuzumab anti-HER2 Fab Light Chain 9606
152 3GRW 2 L Fab light chain 9606
153 6B3K 2 L Light chain of Fab BL3-6 10090
154 5I1D 1 A, L FAB LIGHT CHAIN 9606
155 5VKK 2 B, L Epratuzumab Fab Light Chain 10090
156 6AYZ 2 C, D Fab Light Chain 9606
157 6O3A 1 A Antibody F7.B Fab, Light chain 9606
158 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606
159 4LKC 1 A Fab fragment of PCSK9 antibody 9606
160 4KZD 2 L BL3-6 Fab antibody, light chain 10090
161 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606
162 6O1F 4 L Light Chain hu31A.v11 9606
163 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606
164 5IES 2 L VRC01cHuGL2 Fab light chain 9606
165 6OCB 2 L Light chain of FluA-20 Fab 9606
166 6RCS 2 B R5.016 light chain 9606
167 3S34 1 L 1121B Fab light chain 10090
168 6B6Z 1 A, C Apo Fab Light Chain 9606
169 6EMJ 2 B, L fAb light chain 9606
170 5W1G 2 L CR1-07 Fab light chain 9606
171 6CNR 1 L Aducanumab light chain 9606
172 6PLK 2 L, M ZIKV-116 light chain 9606
173 6OKM 2 L Fab 3C8 light chain 9606
174 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630
175 4NRX 3 B, E, L m66 Light Chain 9606
176 3O2D 1 L ibalizumab light chain 10090
177 6DB9 3 L Fab-Light-Chain 32630
178 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606
179 5O14 3 D, L Fab 1A12 Light Chain 9606
180 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606
181 6B5O 2 L CIS43 Fab Light chain 9606
182 2R0L 1 L antibody light chain 32630
183 5BK1 2 D, L Synthetic antibody, Fab fragment, Light Chain 9606
184 6N32 1 L, M Fab 2G12 light chain 9606
185 6TYB 4 L NEUTRALIZING ANTIBODY ITS90.03 FAB LIGHT CHAIN 9544
186 6DWC 1 A, L 4497 Fab Light Chain 9606
187 5VR9 2 B, L CH1/Ckappa Fab light chain 9606
188 5VZ1 1 A, C Apo Antibody Fab Light Chain 9606
189 5OD8 2 B B2 Fab fragment - Light chain 9606
190 3KR3 3 L antibody-Fab (light chain) 9606
191 6DZN 1 L Antibody ADI-15878, light chain 9606
192 5GGU 2 B, L light chain 9606
193 5KW9 3 L IgA Light chain 9606
194 5W2B 2 L Fab Light Chain 9606
195 6E4X 2 Y S5V2-29 light chain 9606
196 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
197 6AXL 1 B, C Fab317 light chains 9606
198 6HIG 2 L Light Chain 10090
199 6CXG 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
200 6CO3 1 L Fab light chain 9606
201 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606
202 3BN9 2 C, E E2 Fab Light Chain 9606
203 6DZR 2 L h38c2 light chain 9606
204 6DF0 1 L 4G10-4D5 Antibody Light chain 32630
205 6U9U 2 L GM9_TH8seq732127 FAB light chain 9606
206 6DF1 1 L Anti-phosphotyrosine antibody 4G10-4D5 heavy chain 9606
207 3L95 1 A, L anti-NRR1 fab fragment light chain 9606
208 4OGX 3 L DX-2930 LIGHT CHAIN 9606
209 4KZE 2 L BL3-6 Fab antibody, light chain 10090
210 6MU3 1 K, L Fab 2G12, light chain 9606
211 4XVU 3 D, F, J, L Antibody light chain 32630
212 5B71 1 A, C SKY59 Fab light chain 9606
213 6BF4 3 C, L VRC-PG05 Fab light chain 9606
214 3NAB 1 L Fab15 Mut6 light chain 9606
215 4Q9Q 2 L Fab BL3-6, LIGHT CHAIN 10090
216 4WV1 3 A, D Fab light chain 9606
217 5EII 2 B, L Fab Light Chain 9606
218 4FNL 2 L, M Antibody C05, Light Chain 9606
219 4UB0 2 L IgG1, light chain 9606
220 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
221 1BJ1 1 J, L Fab fragment, light chain HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090
222 6BFT 1 B, L Avastin Light Chain Fab fragment mutant 9606
223 3IDX 3 L Fab b13 light chain 9606
224 5IF0 2 B, L VRC01c-HuGL2 Fab light chain 9606
225 4K94 1 L Fab19 heavy chain 9606
226 5K9Q 4 I, K, L, T, V, Y 16.a.26 Light chain 9606
227 6B5L 2 L CIS43 Fab Light Chain 9606
228 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606
229 5VEB 2 B, L anti-CDH6 Fab light chain 9606
230 6N81 2 D, L A1227 Fab light chain 9606
231 5E08 2 L Fab Light Chain 9606
232 6AZ2 3 E, F Fab Light Chain 9606
233 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN 10090
234 4XAK 3 E, L Light chain of neutralizing antibody m336 9606
235 5JQ6 3 L Tefibazumab FAB FRAGMENT LIGHT CHAIN 10090
236 6DF2 1 A, L Anti-phosphotyrosine antibody c310-4D5 heavy chain 32630
237 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090
238 6AL4 1 A, C, E B43 LIGHT CHAIN 9606
239 4EDW 2 L tanezumab Fab light chain 9606
240 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
241 4NM4 1 L, M Antibody CR8043, Light Chain 9606
242 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606
243 4G7V 2 L fragment antibody light chain 9606
244 4HFW 1 A, L 6-26 Fab Light chain 9606
245 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
246 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606
247 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090
248 5JO4 4 D G6 Fab Light Chain 9606
249 3INU 2 L, N KZ52 antibody fragment light chain 9606
250 5EU7 3 C, D FAB light chain 9606
251 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606
252 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606
253 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606
254 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606
255 3EYV 1 A, L hu3S193 Fab, light chain 10090
256 6Q20 2 L 1E01 Fab kappa light chain 9606
257 5IJK 3 C, D 1E03 Fab fragment light chain 9606
258 3BDY 2 L Fab Fragment -Light Chain 9606
259 5I8E 2 B, D VRC34.01 Fab light chain 9606
260 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606
261 5UIX 2 L DH576 Fab light chain 9606
262 3K2U 4 L Antibody, Fab fragment, Light Chain 9606
263 5VSH 2 B, D, F, L CH1/Clambda Fab light chain 9606
264 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090
265 2HFG 1 L CB3s Fab light chain (kappa) 9606
266 3GKW 2 L Light chain of the antibody Nimotuzumab 9606
267 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606
268 5ZIA 2 B, E, I, L, M, P Light chain (kappa) of CBTAU-24.1 antibody 9606
269 4JQI 3 L Fab30 light chain 10090
270 6B0H 3 A, C 1262 antibody, light chain 9606
271 6U8C 2 C, L Antibody light chain Fab 9606
272 3SKJ 1 L, M Antibody, light chain 9606
273 3U30 2 B, E Light chain Fab 9606
274 6MFJ 2 B, L DH677.3 Fab light chain 9606
275 5HYS 2 B, D, F, L Uncharacterized protein 9606
276 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606
277 5I15 1 L FAB LIGHT CHAIN 9606
278 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606
279 6U8K 3 E, G, L Light chain of Fab HCV3 Light chain of Fab HCV3 9606
280 5I1E 1 L FAB LIGHT CHAIN 9606
281 4JLR 2 B, L Motavizumab Fab light chain 9606
282 2QQK 3 L Antibody Light Chain 9606
283 4J1U 1 A, C, E antibody 93F3 Light chain 10090
284 4RRP 1 A, B, C, D, E, F Fab antibody, light chain 9606
285 5SX5 1 K, L Panitumumab Fab Light Chain 9606
286 4XGZ 2 B, D, F, I, K, L, N, P, R, T, V, X FAB LIGHT CHAIN 9606
287 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090
288 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606
289 5BK2 3 D, L sAB Light Chain 9606
290 1TZH 2 A, L Fab YADS1 Light Chain 10090
291 5O1R 3 L, M Uncharacterized protein 9606
292 4JZJ 3 B, L Fab Light Chain 10090
293 5BO1 3 L, M Fab light chain 9606
294 6FOE 2 B, L Fab BaxB01 light chain engineered Fab light chain binds oxidized macrophage migration inhibitory factor (MIF) 9606
295 4M6O 1 L CNTO7309 light chain 9606
296 5LSP 3 L, T 107_A07 Fab light chain 9606
297 6MWN 3 D, L Fab HAVx Light Chain 9606
298 4DVR 2 L Fab 48d Light chain 9606
299 6PI7 2 B, E Uncharacterized protein 9606
300 5BK3 1 B, D, F, L 580 Antibody, light chain 9606
301 6HXW 3 D, L IPH53 light chain 32630
302 4XWO 3 D, F, J, L, P, R, V, X Antibody light chain 32630
303 4ZFF 2 B, L Fragment antigen binding (Fab) 5A12 Light chain 9606
304 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606
305 6BGT 2 A Herceptin light chain mutant 9606
306 5FUZ 2 L 645 FAB, LIGHT CHAIN 9606
307 3DVG 1 A Human IgG1 fab fragment light chain 9606
308 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606
309 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606
310 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606
311 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606
312 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090
313 2FJG 2 A, L Fab light chain 9606
314 4DKF 3 L, M FAb2 Light Chain 9606
315 5TLK 3 C, G H2191 LIGHT CHAIN 10090
316 6OGX 2 D Fab1 Light Chain 9606
317 6OGX 5 L Fab2 light chain 9606
318 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606
319 6MEJ 5 L antibody HEPC3 Light Chain 9606
320 3EFD 1 L FabL 10090
321 4LF3 1 A, D Fab heavy chain 10090
322 6IAP 2 D Fab NKp46-4 light chain 32630
323 6IAP 5 L Fab NKp46-1 light chain 32630
324 5K59 4 F, L Fab light chain 9606
325 6MUB 1 K, L Fab 2G12, light chain 9606
326 6BFQ 2 B, D, F, L Fab Light Chain 9606
327 6PZF 2 E, L NA-63 Fab light chain 9606
328 5KN5 2 B, E Epiregulin Antibody LY3016859 Fab Light Chain 9606
329 6O3B 1 A, E Antibody Fab F6, Light chain 9606
330 5F3H 2 B, D, F, H humanized RK35 antibody light chain 10090
331 4LEO 2 B RG7116 Fab light chain 10090
332 4G7Y 2 L Fragment antibody light chain 9606
333 4PY8 4 J antibody 3.1 light chain Fab 9606
334 3DVN 1 A, L Human IgG1 fab fragment light chain 9606
335 3IXT 1 B, L Motavizumab Fab light chain 10090
336 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598
337 1BBJ 1 A, L IGG4-KAPPA B72.3 FAB (LIGHT CHAIN) 10090
338 6U85 2 L antibody Fab Light chain 9606
339 5I1I 1 L FAB LIGHT CHAIN 9606
340 4NNP 3 L, Y Light chain of antagonistic fab fragment 9606
341 4ERS 1 L Fab light chain 9606
342 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606
343 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
344 3SQO 3 L J16 Light chain 9606
345 4K3J 4 L Onartuzumab Fab light chain 10090
346 6PE8 2 B, L FAB Light chain 9606
347 6CYF 2 C, E, L, T IgG1 antibody, kappa light chain 9606
348 6MNF 1 K, L Fab 2G12, light chain 9606
349 4PY7 2 B, J antibody 3.1 light chain Fab 9606
350 6AL5 2 L B43 LIGHT CHAIN 9606
351 4K8R 3 C Fab1, light chain 9606
352 6HHC 1 L FXIA ANTIBODY FAB LIGHT CHAIN 9606
353 6ML8 4 L C05 antibody Fab light chain 9606
354 1TZI 1 A Fab YADS2 Light Chain 10090
355 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090
356 4X7T 2 B, L Omalizumab-Fab Light chain 9606
357 4YK4 1 B, Y 641 I-9 VLCL antibody 9606
358 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606
359 1MHP 3 L, Y FAB FRAGMENT, light chain 10090
360 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544
361 6MEI 3 L antibody HEPC3 Light Chain 9606
362 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606
363 2QQL 3 L Antibody Light Chain 9606
364 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606
365 5SX4 1 I, L Panitumumab Fab Light Chain 9606
366 3WD5 2 L Adalimumab Light Chain 9606
367 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606
368 5GZO 3 D, L Antibody light chain 9606
369 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
370 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606
371 4FP8 3 L, M, N, O Antibody C05, light chain 9606
372 6R2S 1 A Antibody DB9 light chain 9606
373 6I8S 3 I, J, K, L LIGHT CHAIN OF FAB FRAGMENT FROM AN PAI-1 ANTIBODY FAB FRAGMENT 9606
374 6CW2 4 B antibody light chain 9606
375 3BE1 3 L Fab Fragment-Light Chain 9606
376 2FJH 2 A, L Fab fragment light chain 9606
377 5XEZ 3 D, L Antibody, mAb1, light chain 9606
378 4K9E 1 L light chain 10090
379 3P0V 1 L, M Fab DL11 light chain 9606
380 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606
381 6OEL 5 L engineered Fab light chain 9606
382 5VIG 2 B, L Fab light chain 9606
383 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606
384 6I04 3 D, L Fab light chain 9606
385 5VYF 1 A, L Antibody light chain 10090
386 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606
387 4K7P 4 L antibody 10C4 Fab fragment light chain 10090
388 5WUX 2 B, D, L light 9606
389 3OB0 1 K, L Fab 2G12, light chain Fab 9606
390 6MFP 4 D, L DH677.3 Fab light chain 9606
391 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606
392 6GK7 1 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-27.1(S31Y,T100I) FAB ANTIBODY FRAGMENT 9606
393 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606
394 4I18 1 B, L antibody light chain Fab 10090
395 4Q9R 2 L Fab BL3-6, LIGHT CHAIN 10090
396 3IDY 3 C, L Fab b13 light chain 9606
397 3IVK 1 B, L Fab light chain man 10090
398 5I19 1 L FAB LIGHT CHAIN 9606
399 5TH9 1 L, M, N GS-5745 Fab light chain 9986
400 6OKN 2 B, D Fab 1A7 light chain 9606
401 6OC3 2 B, D Light chain of FluA-20 Fab 9606
402 6NZ7 4 I, L 429 B01 FAB light chain 9606
403 5X8L 2 K, L, M, N, O atezolizumab light chain 9606
404 5UDC 2 C, G, L MEDI8897 Fab Light Chain 9606
405 6GK8 2 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-28.1(S32R;E35K) FAB ANTIBODY FRAGMENT 9606
406 5FEC 2 B, L germline 3BNC60 light chain 9606
407 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606
408 2R56 2 L, M IgE Fab Fragment, light chain 9606
409 1ZA6 1 A, C, E, G IGG Light chain 9606
410 4ZS6 1 D, L fab Light Chain 9606
411 4Z5R 2 A, J, L, P, R, T, V, Y anti-IFN-a antibody rontalizumab light chain 9606
412 6APB 3 L ADI-14359 Fab Light Chain 9606
413 5CD3 2 B, D, F, H DRVIA7 Light Chain 9606
414 6D01 2 B, D, F, H 1210 Antibody, Light chain 9606
415 6Q23 3 F, I, K, L 1G01 Fab kappa light chain 9606
416 5CZV 3 L Fab 20350 light chain 9606
417 5XF1 3 D, L Antibody mAb1 Light chain 9606
418 4P59 3 L MOR09825 Fab fragment light chain 9606
419 5XXY 2 L light chain of atezolizumab fab 9606
420 5CJO 3 L FAB light chain 10090
421 4LMQ 3 I, L Stromal cell-derived factor 1 9606
422 3N85 2 L Fab37 Light Chain 9606
423 3G6J 3 E, G Fab light chain 9606
424 5GJT 3 L light chain of human neutralizing antibody 3E1 light chain of neutralizing antibody 3E1 9606
425 6MH2 1 A, C Herceptin Fab arm light chain 9606
426 6K7O 3 C, E, G, L h128-3 Fab light chain 9606
427 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606
428 5O4G 2 A MF3958 FAB light chain 9606
429 6PE9 2 B, D, F, L, M FAB Light chain 9606
430 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606
431 4DKE 3 L, M FAb1.1 Light Chain 9606
432 5VIC 2 L Fab light chain 9606
433 6MEK 3 D, L HEPC3 Light Chain 9606
434 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606
435 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606
436 5GJS 3 L light chain of human neutralizing antibody 3E1 9606
437 6Q1Z 2 C, L 1G04 Fab kappa light chain 9606
438 4NRY 1 B, L m66 Heavy Chain 9606
439 6OE4 2 C, F CR9501 Fab Light Chain 9606
440 6N2X 1 K, L Fab 2G12 light chain 9606
441 3S37 1 L 1121B Fab light chain 10090
442 5XHF 1 A, C polypeptide (L chain) 10090
443 5VL7 4 L Fab33 light chain 9606
444 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090
445 6P8N 3 D, L P-p1f1 Light Chain 10090
446 6DEZ 1 A, L Anti-phosphotyrosine antibody PY20-4D5 light chain 32630
447 1S78 2 C, E Pertuzumab Fab light chain 10090
448 4NYL 1 B, D, F, L Adalimumab Light Chain 9606
449 5D1Z 1 A, H Y10 Light Chain 9606
450 5D1Z 3 C, E D4-10 Light Chain 9606
451 4XHJ 3 C, G Fab-RC light chain 9606
452 5O4O 1 A MF3178 FAB light chain 9606
453 5HJ3 4 B, F, J, N KZ52 Antibody Fragment 9606
454 5D1Q 1 A D2-06 Light Chain 9606
455 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606
456 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598
457 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
458 5XHV 3 L, Q S40 light chain 9606
459 4IOF 3 D, F Fab-bound IDE, light chain 10090
460 5FUO 3 L FAB LIGHT CHAIN 9606
461 4JHW 2 L D25 light chain 9606
462 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606
463 6CXL 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
464 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606
465 4M1C 3 D, F Fab-bound IDE, light chain 9606
466 5UQY 3 C, G, K, O MR78 Fab light chain 9606
467 6D0U 3 D, F, I, L Antibody C05, light chain 9606
468 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606
469 3ULV 2 L Fab15 light chain 9606
470 3ULV 6 E Fab1068 light chain 9606
471 4M7L 2 L 10H10 light chain SEE REMARK 999 10090
472 6OUS 4 N, P, R, T, V, X RB1 Fab Light chain 9606
473 6P8M 3 L P-p3b3 Light Chain 10090
474 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606
475 5UOE 3 L, N, Q, T, W FAB light chain 9606
476 5VL3 3 B, D, F, L Epratuzumab Fab Light Chain 10090
477 5JW3 4 L MEDI8852 light chain 9606
478 6D11 2 B, D 1450 Antibody, Light chain 9606
479 3S36 1 L 1121B light chain 10090
480 5CWS 1 A, G sAB-158 Fab Light Chain 9606
481 5I5K 3 L, Y Eculizumab light chain (variable domain) 9606
482 2R0K 2 L antibody light chain of Fab58 9606
483 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606
484 5C8J 2 B, D, F, H Antibody fragment, light chain OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC 9606
485 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606
486 4G80 3 B, D, F, H fragment antibody light chain 9606
487 3JWO 3 L FAB 48D LIGHT CHAIN 9606
488 5CD5 3 D DRVIA7 Fab Light Chain 9606
489 3P11 2 L Fab DL11 light chain 9606
490 3ULU 2 L Fab15 light chain 9606
491 3ULU 6 E Fab1068 light chain 9606
492 5W1K 1 A, F, K, S CR1-28 Fab light chain 9606
493 4XI5 3 C Fab-94 light chain 9606
494 5WOB 4 J, L, N, P, R, T, V, X IDE-bound Fab light chain 60742
495 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606
496 6EAY 1 L CA45 light chain 9541
497 5G64 3 L, M FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-218 9606
498 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606
499 5W1M 1 A, C, E, G CR1-07 Fab light chain 9606
500 6RCV 4 D, I R5.016 light chain 9606
501 5JW4 4 N, P, T, V, X MEDI8852 light chain 9606
502 5JW4 6 R MEDI8852 light chain 9606
503 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606
504 5UDD 3 P, Q, R, S, T, U MEDI8897 Fab Light Chain 9606
505 5J3D 2 B, D, L 14N4 light chain 9606
506 4R4N 3 D, G, K, L, O, R, U, X Antibody 2.2c LIGHT CHAIN 9606
507 3EFF 1 A, C FAB 10090
508 3PJS 1 A, C FAB light chain 10090
509 6OE5 3 C Motavizumab Fab Light Chain 10090
510 6OE5 5 L CR9501 Fab Light Chain 9606
511 6MAM 2 B, D, F ADI-15946 Fab Light Chain 9606
512 5O7P 2 A MF3178 FAB light chain 9606
513 4ZYP 3 L, M, O Motavizumab antibody light chain 10090
514 4ZYP 5 E, G, I AM14 antibody light chain 9606
515 6RCU 4 D R5.016 light chain 9606
516 5DWU 4 L Fab - Light Chain 9606
517 5V2A 3 L Light chain (kappa) of H7.167 antibody Fab 9606
518 6EA7 4 L, N, R ADI-15878 Fab Light Chain 9606
519 5I8H 5 F, H VRC34.01 Fab light chain 9606
520 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606
521 4R4H 3 L Antibody 2.2c, Light chain 9606
522 6EA5 4 L, N, R ADI-15878 Fab Light Chain 9606
523 5FHC 5 L Antibody 114 Fab light chain 9606
524 4XMN 6 L Antibody 87 light chain 32630
525 4XMM 8 L Antibody 57 light chain 9606
526 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606
527 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606
528 6UKJ 3 L Fab Light Chain 9606
529 6U02 2 C, F, I, L Fab-63 Light Chain 9606
530 6PZZ 2 E, G, J, L NA-80 fragment antibody light chain 9606
531 6PWC 5 L Fab30 light chain 32630
532 6OT0 5 L Fab light chain 10090
533 6OGE 2 B Pertuzumab FAB LIGHT CHAIN 9606
534 6OGE 4 D Trastuzumab FAB LIGHT CHAIN 9606
535 6QD8 1 L, Y, Z Light chain 9606
536 6NI2 4 L Fab30 Light Chain 32630
537 6NC3 4 L, T, U, V, W, X Monoclonal antibody VRC34.01 fragment antigen binding light chain 9606
538 6MLM 4 G, I, L Light chain Fv of H7.5 Fab 9606
539 6MJZ 3 L PIA174 Fab Light chain 9606
540 6E5P 1 1, 4, K, L, Q, T 2G12 Light chain 9606
541 6E1K 2 C, E cat06 light chain 9606
542 6CMO 5 L Fab light chain 32630
543 6BF7 3 D, F Fab H11-E light chain 10090
544 6BF9 3 D, F Fab H11-E light chain 10090
545 6B7Z 3 D, F FAB H11 light chain 10090
546 6B70 3 D, F FAB H11-E light chain 10090
547 3J70 2 B, N, S monoclonal antibody 17b heavy chain 9606
548 3CM9 3 L, M, N, O Ig alpha-2 chain C region 9606
549 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606
550 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606
551 2ESG 1 L, M Immunoglobulin A1 light chain 9606
552 1R70 1 A, C Human IgA2(m1) Light Chain 9606
553 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606